Substance
SPARSENTAN
Global reference: every product and company linked to this substance.
- cas: 254740-64-2
- ncit: C152412
- pubchem_cid: 10257882
- unii: 9242RO5URM
FILSPARI · PS-433540 · PS433540 · RE-021 · sparsentan [INN] · SPARSENTAN [USAN] · Sparsentan [WHO-DD]
Revenue by product (1)
| Company | Product | Latest period | Revenue |
|---|---|---|---|
| TRAVERE THERAPEUTICS INC. COMMON STOCK | FILSPARI | Q2 2026 | $141.1M |
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.
Products containing this substance (1)
- FILSPARI · TRAVERE THERAPEUTICS INC. COMMON STOCK